|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:MARCKS-LOC105372074 (FusionGDB2 ID:51729) |
Fusion Gene Summary for MARCKS-LOC105372074 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MARCKS-LOC105372074 | Fusion gene ID: 51729 | Hgene | Tgene | Gene symbol | MARCKS | LOC105372074 | Gene ID | 4082 | 105372074 |
| Gene name | myristoylated alanine rich protein kinase C substrate | uncharacterized LOC105372074 | |
| Synonyms | 80K-L|MACS|PKCSL|PRKCSL | - | |
| Cytomap | 6q21 | 18q12.2 | |
| Type of gene | protein-coding | ncRNA | |
| Description | myristoylated alanine-rich C-kinase substratemyristoylated alanine-rich protein kinase C substrate (MARCKS, 80K-L)phosphomyristinprotein kinase C substrate, 80 kDa protein, light chain | - | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P29966 | . | |
| Ensembl transtripts involved in fusion gene | |||